Christine Ring
Known title: Chief Legal OfficerCIK: 0001817199
Associated companies
Transaction History
| NRIX | ▲ Buy | Option Exercise | 5,786 | $50K | 10/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,786 | $134K | 10/2/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,787 | $50K | 9/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,387 | $138K | 9/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 400 | $11K | 9/2/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,787 | $50K | 8/3/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 16,589 | $382K | 8/3/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,847 | $90K | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,572 | $0 | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,221 | $10K | 7/2/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,787 | $50K | 7/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 11,008 | $259K | 7/2/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 13,333 | $97K | 6/25/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 15,602 | $136K | 6/25/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 28,935 | $581K | 6/25/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,422 | $6K | 6/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 8,148 | $135K | 6/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 8,148 | $138K | 5/4/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,394 | $90K | 5/1/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,214 | $53K | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 4/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 8,148 | $124K | 4/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 8,148 | $126K | 3/2/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 14,261 | $238K | 2/9/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,925 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,859 | $0 | 1/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,333 | $72K | 1/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 88 | $2K | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,760 | $7K | 1/20/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,760 | $69K | 1/20/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,760 | $7K | 12/18/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,560 | $64K | 12/18/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 200 | $4K | 12/18/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 37,600 | $70K | 11/24/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 37,600 | $642K | 11/24/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 10/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,644 | $47K | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 7/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,841 | $46K | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 4/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,894 | $33K | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 223 | $415 | 1/31/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,537 | $10K | 1/31/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 100 | $2K | 1/31/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,660 | $113K | 1/31/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 291 | $6K | 1/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,929 | $58K | 1/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,760 | $112K | 1/2/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,760 | $11K | 1/2/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,760 | $11K | 12/2/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,760 | $125K | 12/2/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,290 | $31K | 11/4/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,290 | $82K | 11/4/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,760 | $11K | 11/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,760 | $140K | 11/1/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 10/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 10/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,182 | $102K | 10/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,290 | $82K | 10/14/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,290 | $31K | 10/14/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,760 | $11K | 10/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,460 | $121K | 10/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 300 | $7K | 10/1/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,760 | $11K | 9/3/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,290 | $31K | 9/3/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 200 | $5K | 9/3/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 8,850 | $221K | 9/3/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 4,463 | $8K | 8/26/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,407 | $52K | 8/26/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 9,870 | $247K | 8/26/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,760 | $11K | 8/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,460 | $117K | 8/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 300 | $7K | 8/1/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,920 | $60K | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 5,760 | $11K | 7/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,959 | $103K | 7/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 801 | $17K | 7/1/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,864 | $3K | 6/13/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,864 | $32K | 6/13/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,900 | $4K | 6/12/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,900 | $32K | 6/12/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 400 | $744 | 6/5/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 400 | $7K | 6/5/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,596 | $3K | 6/3/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,596 | $27K | 6/3/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 4/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,513 | $18K | 4/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 1/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,760 | $14K | 1/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,232 | $6K | 10/31/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 10/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,420 | $14K | 7/31/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 7/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 682 | $7K | 5/1/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 4/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 1/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 848 | $10K | 1/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 699 | $9K | 10/31/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 10/30/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 712 | $11K | 8/1/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 7/30/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 660 | $8K | 5/2/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,924 | $0 | 4/30/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,200 | $2K | 1/10/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,200 | $33K | 1/10/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,200 | $35K | 12/10/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,200 | $2K | 12/10/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,200 | $2K | 11/10/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,200 | $39K | 11/10/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 800 | $1K | 10/27/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 800 | $28K | 10/27/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,200 | $33K | 10/11/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 1,200 | $2K | 10/11/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $4K | 9/10/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 500 | $18K | 9/10/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 700 | $25K | 9/10/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 800 | $29K | 9/10/2021 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,200 | $6K | 9/7/2021 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,200 | $113K | 9/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Nurix Advances Bexobrutideg Studies and Secures $10M Gilead Extension
Nurix has enrolled its first patient in a Phase 1b/2 study of Bexobrutideg for chronic lymphocytic leukemia, and a second enrollment began for a Bexobrutideg plus Venetoclax combination under a Roche partnership. The company also received a second research term extension for its oncology program with Gilead Sciences and secured $10 million from Gilead as part of the extended drug‑discovery collaboration. These developments show ongoing progress in Nurix’s pipeline and continued partnership support.
Nurix Advances Bexobrutideg Studies and Secures $10M Gilead Extension. Nurix has enrolled its first patient in a Phase 1b/2 study of Bexobrutideg for chronic lymphocytic leukemia, and a second enrollment began for a Bexobrutideg plus Venetoclax combination under a Roche partnership. The company also received a second research term extension for its oncology program with Gilead Sciences and secured $10 million from Gilead as part of the extended drug‑discovery collaboration. These developments show ongoing progress in Nurix’s pipeline and continued partnership support.